STIM 0.75 (-57.87%)
US64131A1051Medical Diagnostics & ResearchDiagnostics & Research

Neuronetics (STIM) Competitor Comparison

We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - STIM ranking 39 / 58

These are the competitors of Neuronetics in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
123.24
2. Inotiv NOTV
78.09
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. DarioHealth DRIO
31.71
5. Syneos Health SYNH
24.79
6. Heska HSKA
15.42
7. CareDx CDNA
14.17
8. Myriad Genetics MYGN
9.05
9. Anixa Biosciences ANIX
8.98
10. Olink Holding OLK
8.53
11. NeoGenomics NEO
7.68
12. Qiagen QGEN
7.25
13. Pacific Biosciences of California PACB
7.11
14. Aspira Womens Health AWH
5.9
15. Twist Bioscience TWST
5.7
16. Charles River Laboratories CRL
5.44
17. DexCom DXCM
5.34
18. Fulgent Genetics FLGT
5.09
19. PerkinElmer PKI
4.97
20. Illumina ILMN
4.5
21. Neogen NEOG
4.36
22. Trinity Biotech TRIB
4.22
23. Quest Diagnostics DGX
4.19
24. Sotera Health SHC
4.04
25. IQVIA Holdings IQV
3.84
26. Laboratory Corp of America Holdings LH
3.72
27. Exact Sciences EXAS
3.65
28. Waters WAT
3.39
29. Enzo Biochem ENZ
3.34
30. IDEXX Laboratories IDXX
3.3
31. Sera Prognostics SERA
3.26
32. National Research NRC
3.12
33. Guardant Health GH
3.03
34. Psychemedics PMD
2.99
35. Agilent Technologies A
2.66
36. Personalis PSNL
2.63
37. Bioventus BVS
2.42
38. Interpace Biosciences IDXG
2.36
39. Neuronetics STIM
2.35
40. Mettler-Toledo MTD
2.26
41. Exagen XGN
2.26
42. Global Cord Blood CO
2.23
43. Precipio PRPO
2.16
44. MDxHealth MDXH
2.14
45. MaxCyte MXCT
2.14
46. Thermo Fisher Scientific TMO
2.03
47. Biodesix BDSX
1.99
48. Danaher DHR
1.92
49. Prenetics Global PRE
1.88
50. Icon ICLR
1.84
51. bioAffinity Technologies BIAF
1.65
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.48
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.82
56. RadNet RDNT
0.38
57. Lantheus Holdings LNTH
0.31
58. Medpace Holdings MEDP
0.31

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.